Trillium Therapeutics Inc.
(89620X506)
Funds Reporting Holdings of Trillium Therapeutics Inc. according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Matrix Capital Management Company LP | 2,288,560 | $753k | Jun 30, 2019 | Aug 14, 2019 | |
Baker BROS Advisors LP | 505,262 | $166k | Jun 30, 2019 | Aug 14, 2019 | |
Tekla Capital Management LLC | 446,099 | $146k | Jun 30, 2019 | Aug 14, 2019 |